APA (7th ed.) Citation

Takusagawa, S., Treijtel, N., Saito, M., Michon, I., Miyatake, D., Osaki, F., . . . de Vries, M. (2024). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M3 Receptor‐Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers. Clinical Pharmacology in Drug Development, 13(10), 1130. https://doi.org/10.1002/cpdd.1460

Chicago Style (17th ed.) Citation

Takusagawa, Shin, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M3 Receptor‐Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers." Clinical Pharmacology in Drug Development 13, no. 10 (2024): 1130. https://doi.org/10.1002/cpdd.1460.

MLA (9th ed.) Citation

Takusagawa, Shin, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M3 Receptor‐Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers." Clinical Pharmacology in Drug Development, vol. 13, no. 10, 2024, p. 1130, https://doi.org/10.1002/cpdd.1460.